Gyurci John 4
4 · MiniMed Group, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
MiniMed (MMED) VP/Chief Accounting Officer John Gyurci Receives RSU Award
What Happened John Gyurci, Vice President and Chief Accounting Officer of MiniMed Group, Inc. (MMED), was granted 15,322 restricted stock units (RSUs) on March 11, 2026. The grant was a conversion of previously held Medtronic awards into MMED RSUs as part of MMED’s separation from Medtronic. No per-share price or cash value is reported (price = N/A); these are time-vesting equity awards rather than an open-market purchase or sale.
Key Details
- Transaction date (reporting period): March 11, 2026; Form 4 filed March 13, 2026 (timely).
- Transaction type: Award/Grant (code A) — 15,322 MMED RSUs granted.
- Price/Value: N/A (conversion of prior Medtronic awards; no cash purchase).
- Vesting: The RSUs vest in three equal installments on Jan 26, 2027; Jan 26, 2028; and Jan 26, 2029.
- Conversion mechanics: The Medtronic awards were converted to MMED RSUs under the Employee Matters Agreement and based in part on average Medtronic and MMED closing prices around the separation dates.
- Plan: Grants made under the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP).
- Shares owned after the transaction: Not disclosed in the provided Form 4 details.
- Remarks: Grant resulted from MMED’s separation from Medtronic; these are time-vesting awards, not immediate stock ownership.
Context This filing reflects an equity award conversion tied to a corporate separation, not a purchase or sale. Converted RSUs typically do not represent immediately tradable shares — value and ownership crystallize as the units vest (and may be subject to withholding or other plan terms). Such awards are routine when companies spin off or separate and do not by themselves indicate insider buying or selling intent.
Insider Transaction Report
- Award
Common Stock
[F1][F2][F3][F4]2026-03-11+15,322→ 15,322 total
Footnotes (4)
- [F1]In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").
- [F2]Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").
- [F3]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest in three equal installments on January 26, 2027, January 26, 2028, and January 26, 2029.
- [F4]Includes shares to be issued in connection with the vesting of one or more restricted stock units.